Added to YB: 2026-02-11
Pitch date: 2026-02-09
HIMS [neutral]
Hims & Hers Health, Inc.
-15.4%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$3.7B
Pitch Price
$18.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
23.63
P/E
30.31
EV/Sales
1.90
Sector
Health Care Providers and Services
Category
special_situation
The Hassle Around $HIMS Explained + My Opinion
HIMS (hold): FDA shortage end forced exit from profitable compounded semaglutide injectables. Attempted pivot to $49/mo oral version faced legal challenges from Novo & FDA over missing SNAC absorption tech, forcing another exit. Stock -20% single day. Positive: labs launch, Canada/UK expansion, cancer testing. Holding pending clarity on GLP-1 pivot strategy.
Read full article (5 min)